To assess the potential contribution of collagens and fibronectin on the therapeutic sensitivity of ALK+ NSCLC to ALKi, we contrasted the responses of H3122 and STE-1 cells grown on regular tissue culture plastic with those grown on collagen-coated or fibronectin-coated plates. The gene discussed is ALK; the disease is non-small cell lung carcinoma.